Leerink: Time To Buy Nabriva Therapeutics' 'Unique Differentiation' By: Benzinga via Benzinga October 13, 2015 at 08:49 AM EDT Nabriva Therapeutics AG – ADR (NASDAQ: NBRV) shares have plunged 24 percent since September 21, while hovering close to the ... Read More >> Related Stocks: Paratek Pharma Inc Tetraphase Pharmaceu